The newly announced partnership between GeneMarkers and Genoskin is one that will accelerate clinical testing and, as a result, potentially accelerate product development and benefit claims as they pertain to the trendy new skin care ingredient that is CBD.
GeneMarkers specializes in genomic testing. And according to the company’s ‘about’ blurb on LinkedIn, “GeneMarkers provides gene expression and genotyping services for pharmaceutical, biotechnology and personal care companies. Studies are used to support all phases of molecular research, from discovery through early clinical trials.”
Massachusetts-based Genoskin got its start in 2011 and specializes in ex vivo testing using skin that’s kept alive in testing wells thanks to a proprietary technology, which means that any testing results are closer to those from a conventional in vivo testing model than a conventional ex vivo model.
According to the company’s ‘about’ blurb on LinkedIn, “Genoskin provides ready-to use and standardised ex vivo human skin models to the biotech, pharma, Medtech, cosmetic and chemical industry. We use donated excess human skin samples that is collected after surgery with the informed consent of the donors.”
Better science through teamwork
“As we look at the future of product development and consider how to enhance our products and services to better serve our clients, a formal partnership with Genemarkers only makes sense,” says Pascal Descargues, founder and CEO of Genoskin.
“Working together,” he says in the company’s media release, “will allow us to streamline procurement, reduce total time from proposal to report and save our clients’ money while delivering industry-leading clinical-grade results.”
And it’s not the first time the 2 companies have worked together, according to Anna Langerveld, president and chief scientific officer of GeneMarkers. “We have worked with Genoskin models in many of our studies,” she tells the press.
Advancing CBD testing for cosmetics and personal care
Earlier this year at the NYSCC Suppliers Day event in New York City, Langerveld and her team were talking with attendees about gene expression testing for CBD. “As a testing lab that specializes in testing services for the cosmetic industry…we’ve seen a lot of interest and a lot of enthusiasm about using CBD in cosmetic products development, particularly related to skin care” Langerveld told Cosmetics Design in a video interview filmed at the Suppliers Day tradeshow.
The company’s new partnership with Genoskin is a deal to bring that testing to the next level. As this week’s media release states, “Genemarkers and Genoskin are pleased to announce they have formed a partnership to provide exceptional value and service to researchers in the fields of cosmetic and pharmaceutical topical solutions. The Companies are currently performing collaborative work to understand how cannabidiol (CBD) acts in the skin.” And that’s something the entire beauty industry is keen to know.
---
Deanna Utroske, CosmeticsDesign.com Editor, covers beauty business news in the Americas region and publishes the weekly Indie Beauty Profile column, showcasing the inspiring work of entrepreneurs and innovative brands.
